SALVADORI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 679
EU - Europa 548
AS - Asia 139
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.371
Nazione #
US - Stati Uniti d'America 679
IT - Italia 228
IE - Irlanda 143
HK - Hong Kong 51
CN - Cina 36
SE - Svezia 34
AT - Austria 25
RO - Romania 20
DE - Germania 15
FI - Finlandia 14
KR - Corea 14
RU - Federazione Russa 13
BE - Belgio 12
FR - Francia 11
GB - Regno Unito 11
PH - Filippine 10
SG - Singapore 7
UA - Ucraina 7
CH - Svizzera 6
VN - Vietnam 5
PL - Polonia 4
AU - Australia 3
JP - Giappone 3
LB - Libano 3
TR - Turchia 3
IR - Iran 2
NL - Olanda 2
UZ - Uzbekistan 2
CL - Cile 1
EU - Europa 1
GR - Grecia 1
IL - Israele 1
IN - India 1
MD - Moldavia 1
NO - Norvegia 1
TW - Taiwan 1
Totale 1.371
Città #
Chandler 191
Dublin 140
Perugia 97
San Mateo 56
Hong Kong 51
Altamura 32
Ann Arbor 32
Redmond 31
Dearborn 28
Medford 28
Princeton 27
Vienna 24
Wilmington 22
Andover 20
Bucharest 19
Lawrence 18
Beijing 16
Brussels 12
Falls Church 11
Cebu City 7
Los Angeles 7
Redwood City 7
Seodaemun-gu 7
Collazzone 6
Des Moines 6
Glasgow 6
Norwalk 6
Saint Petersburg 6
Dong Ket 5
Ashburn 4
Woodbridge 4
Xiamen 4
Dumaguete 3
Helsinki 3
Houston 3
Perth 3
Rimini 3
Cannara 2
Ealing 2
Florence 2
Jinan 2
Karaj 2
Kunming 2
Milan 2
Monreale 2
New York 2
Nürnberg 2
Oneonta 2
Piemonte 2
Raisio 2
Seongnam-si 2
Seoul 2
Sindelfingen 2
Turin 2
Turku 2
Villeurbanne 2
Amsterdam 1
Assisi 1
Bergen 1
Boardman 1
Capannelle 1
Changsha 1
Chicago 1
Chisinau 1
Città Di Castello 1
Costa Mesa 1
Den Haag 1
Fossato Di Vico 1
Frankfurt Am Main 1
Fremont 1
Guangzhou 1
Guidonia 1
Gwanak-gu 1
Hebei 1
Hefei 1
Istanbul 1
Izmir 1
Jarocin 1
Jiaxing 1
Konya 1
Kraków 1
Lausanne 1
Leawood 1
Leno 1
Moscow 1
Nanjing 1
Napoli 1
Philadelphia 1
Phoenix 1
Rehovot 1
San Diego 1
San Paolo di Civitate 1
Seongbuk-gu 1
Simi Valley 1
Singapore 1
Tainan City 1
Timisoara 1
Totale 1.024
Nome #
Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice 111
RAGE in the pathophysiology of skeletal muscle. 88
Generation of an mdx/Ager–/– double mutant mouse. Preliminary data on skeletal muscle architecture. 86
Sertoli cells protect C2C12 myotubes against atrophy and induce utrophin expression in canine and human dystrophic myotubes. 74
Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy 74
Histological muscle characterization in hypertrophied Marchigiana cattle breed 65
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 65
Screening of 100 plant extracts for the development of a herbal product effective against muscle atrophy 61
Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice 60
RAGE and its ligands, S100B and HMGB1, are molecular determinants of cancer-induced muscle wasting. 60
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy 55
The receptor RAGE: a potential molecular target in cancer cachexia 53
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy? 50
Use of Sertoli cells to treat DMD patients is supported by their immunomodulatory rather than immunosuppressive effect 48
Absence of RAGE in an animal experimental model of Duchenne muscular dystrophy results in reduced muscle necrosis and inflammation 46
Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. In vitro data 46
Mdx/Ager–/– mice show reduced muscle necrosis and inflammation compared with mdx mice 45
Sertoli cell-secreted factors have promyogenic and antifibrotic properties on human DMD myoblasts with different mutations. 45
Novel data support the use of microencapsulated Sertoli cells as a potential treatment of DMD patients. 41
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 40
The novel DMD experimental model, mdx/Ager–/– mouse reveals a role of RAGE in inflammatory processes in dystrophic muscles. 39
Natural products to counteract muscle atrophy 38
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 37
Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast Muscle Atrophy and Sarcopenia 34
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 33
Hyperactivated rage in comorbidities as a risk factor for severe covid-19—the role of rage-ras crosstalk 33
Sertoli cells improve myogenic differentiation, reduce fibrogenic markers, and induce utrophin expression in human dmd myoblasts 22
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 20
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 1
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer 1
Totale 1.471
Categoria #
all - tutte 5.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201910 0 0 0 0 0 0 0 0 0 0 5 5
2019/2020137 5 3 0 3 9 21 19 3 56 16 1 1
2020/2021155 1 4 10 4 62 21 24 2 10 8 3 6
2021/2022290 3 40 9 17 6 8 8 75 10 32 43 39
2022/2023548 30 104 3 49 44 61 1 25 198 2 22 9
2023/2024204 15 23 5 23 8 21 80 4 4 14 7 0
Totale 1.471